DE602004024569D1 - Verfahren zur beurteilung des verkrebsungsgrades - Google Patents

Verfahren zur beurteilung des verkrebsungsgrades

Info

Publication number
DE602004024569D1
DE602004024569D1 DE602004024569T DE602004024569T DE602004024569D1 DE 602004024569 D1 DE602004024569 D1 DE 602004024569D1 DE 602004024569 T DE602004024569 T DE 602004024569T DE 602004024569 T DE602004024569 T DE 602004024569T DE 602004024569 D1 DE602004024569 D1 DE 602004024569D1
Authority
DE
Germany
Prior art keywords
assessing
mammal
index value
specimen
cancerous state
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE602004024569T
Other languages
English (en)
Inventor
Toshikazu Ushijima
Atsushi Hagihara
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
JAPAN GOVERNMENT
Sumitomo Chemical Co Ltd
National Cancer Center Japan
Original Assignee
JAPAN GOVERNMENT
Sumitomo Chemical Co Ltd
National Cancer Center Japan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by JAPAN GOVERNMENT, Sumitomo Chemical Co Ltd, National Cancer Center Japan filed Critical JAPAN GOVERNMENT
Publication of DE602004024569D1 publication Critical patent/DE602004024569D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57496—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving intracellular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/154—Methylation markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Food Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE602004024569T 2003-09-16 2004-09-15 Verfahren zur beurteilung des verkrebsungsgrades Expired - Lifetime DE602004024569D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2003322822A JP5116936B2 (ja) 2003-09-16 2003-09-16 哺乳動物由来の検体の癌化度を評価する方法
PCT/JP2004/013871 WO2005026350A1 (ja) 2003-09-16 2004-09-15 癌化度評価方法

Publications (1)

Publication Number Publication Date
DE602004024569D1 true DE602004024569D1 (de) 2010-01-21

Family

ID=34308682

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004024569T Expired - Lifetime DE602004024569D1 (de) 2003-09-16 2004-09-15 Verfahren zur beurteilung des verkrebsungsgrades

Country Status (7)

Country Link
US (1) US7763422B2 (de)
EP (1) EP1679370B1 (de)
JP (1) JP5116936B2 (de)
AT (1) ATE451458T1 (de)
DE (1) DE602004024569D1 (de)
ES (1) ES2336451T3 (de)
WO (1) WO2005026350A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008136404A (ja) * 2006-11-30 2008-06-19 Sysmex Corp Ｄｎａメチル化検出における非メチル化シトシン変換処理後のｄｎａ量の確認方法
SI2371766T1 (sl) 2010-04-01 2013-07-31 Omya Development Ag Postopek za pridobivanje oborine kalcijevega karbonata
WO2013002422A1 (ja) 2011-06-29 2013-01-03 国立大学法人鹿児島大学 膵腫瘍の病型診断方法
ES2616130T3 (es) 2013-08-20 2017-06-09 Omya International Ag Proceso para la obtención de carbonato de calcio precipitado

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL163732A0 (en) 2002-03-07 2005-12-18 Univ Johns Hopkins Genomic screen for epigenetically silenced tumor suppressor genes

Also Published As

Publication number Publication date
ATE451458T1 (de) 2009-12-15
JP5116936B2 (ja) 2013-01-09
EP1679370B1 (de) 2009-12-09
ES2336451T3 (es) 2010-04-13
US20070135366A1 (en) 2007-06-14
EP1679370A4 (de) 2006-11-22
JP2005087046A (ja) 2005-04-07
EP1679370A1 (de) 2006-07-12
US7763422B2 (en) 2010-07-27
WO2005026350A1 (ja) 2005-03-24

Similar Documents

Publication Publication Date Title
WO2007038754A3 (en) Gene expression profiling for identification monitoring and treatment of rheumatoid arthritis
WO2004099432A3 (en) Identification of biomarkers for detecting pancreatic cancer
DE60223561D1 (de) Verfahren zum nachweis von oxidativem stress sowie kit zur durchführung davon
ATE520979T1 (de) Biomarker und verfahren zur bestimmung der empfindlichkeit gegenüber modulatoren des egf(epidermal growth factor)-rezeptors
WO2008063413A3 (en) Gene expression profiling for identification, monitoring, and treatment of lung cancer
WO2008063414A3 (en) Gene expression profiling for identification, monitoring, and treatment of colorectal cancer
DK1372469T3 (da) Fremgangsmåde til bestemmelse af de optiske egenskaber af et flerlaget væv
WO2008148072A3 (en) Disease-associated genetic variations and methods for obtaining and using same
ES2349107T8 (es) Método analítico e instrumento.
KR100711046B1 (ko) 대장암에 대한 마커로서의 니코틴아미드ｎ―메틸트랜스퍼라아제의 용도
ATE482394T1 (de) Verfahren, vorrichtung und programm zur bewertung der immunität sowie datenaufzeichnungsmedium mit darin gespeichertem immunitätsbewertungsprogramm
ATE426175T1 (de) Verfahren zur standardisierung von gerinnungstesten
EP1415152A4 (de) Verfahren, vorrichtungen und computerprogramme zum verifizieren der integrität einer sonde
MY153332A (en) Document of value, method of manufacture and method of detecting soil or wear
ATE525637T1 (de) Verfahren zur messung der trübung eines films
ATE527795T1 (de) Verfahren und system zur schätzung eines symbolzeitfehlers in einem breitband- übertragungssystem
ATE504833T1 (de) Verfahren zur bestimmung des phänotyps von zellen
NO20074246L (no) Fremgangsmate og anordning for a karakterisere de lineaere egenskapene til en elektrisk komponent
ATE492815T1 (de) Diagnostik-biomolekül(e)
DK1853735T3 (da) Fremgangsmåder til detektering af progressionen af cervikal dysplasi i let grad
DE602004024569D1 (de) Verfahren zur beurteilung des verkrebsungsgrades
WO2007072394A3 (en) Audio structure analysis
ATE468535T1 (de) Verwendung von nnmt als marker für lungenkrebs
ATE412182T1 (de) Verwendung der proteine proteinase 3 (prn3) und leukozyten elastatse inhibitor (ileu) als marker für kolorektale karzinome
WO2006080939A3 (en) Spectrum searching method that uses non-chemical qualities of the measurement

Legal Events

Date Code Title Description
8364 No opposition during term of opposition